Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Oral Mucositis Market from 2024 to 2025?
The market size of oral mucositis has seen robust growth in the past few years. The forecast predicts that it will expand from $1.51 billion in 2024 to $1.63 billion in 2025, reflecting a compound annual growth rate (CAGR) of 8.0%. Factors contributing to this growth during the historic period include a rise in cancer instances, an increase in chemotherapy and radiation treatments, an enhanced understanding of oral mucositis, a greater adoption of supportive care therapies, an increase in instances of head and neck cancers, and an uptick in research and development in the field of oncology supportive care.
What Is the Projected Market Size of the Oral Mucositis Market?
The market for oral mucositis is predicted to witness significant expansion in the upcoming years. Expected to reach a value of $2.08 billion by 2029, with a compound annual growth rate (CAGR) of 6.3%. The surge during this forecast period can be linked to the increase in global cancer rates, growing demand for individualized medical treatments, an increasing emphasis on care that alleviates symptom, enhanced patient knowledge and education, increased use of over-the-counter oral care products, an escalation in government and healthcare funding, plus an increased prevalence of radiation and chemotherapy treatments. Key trends anticipated during this forecast period consist of progress in low-level laser therapy, the creation of new drug delivery systems, the incorporation of digital health solutions, the employment of artificial intelligence in treatment strategy, the rise of tissue engineering and healing therapies, and advancements in smart mouthwashes and oral care products.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21237&type=smp
Who are the Major Competitors in the Oral Mucositis Market Outlook?
Major companies operating in the oral mucositis market are Merck & Co Inc., Amgen Inc., Mundipharma International Limited, Swedish Orphan Biovitrum, EUSA Pharma, Galera Therapeutics Inc., Enzychem Lifesciences Corporation, Oragenics Inc., Soligenix Inc., Jaguar Health Inc., Monopar Therapeutics Inc., EpicentRx, BrainCool, Cellceutix Corporation, GlycoMira Therapeutics Inc., Innovation Pharmaceuticals Inc., Allander Biotechnologies, Aurora BioScience, Solasia Pharma KK, NeoMedLight, MuReva (Lumitex), Prothex Pharmaceuticals Inc.
What Is Fueling Growth in the Oral Mucositis Market?
The rise in cancer incidences is anticipated to fuel the growth of the oral mucositis market in the future. Characterized by the unregulated proliferation and spread of anomalous cells that can infiltrate and disintegrate healthy tissues, cancer is an illness that continues to proliferate due to factors like an ageing population, lifestyle alterations, exposure to the environment, infections and hereditary tendencies. The therapy for oral mucositis brings relief to cancer patients by easing pain, decreasing inflammation, averting secondary infections, and facilitating rapid healing of oral tissues. This significantly enhances their comfort, nutrition consumption, and their overall living standard during chemotherapy or radiation therapy. For instance, the National Cancer Institute, a US government agency, revealed in May 2024 that about 20 million new cancer incidences and 9.7 million deaths relating to cancer were documented globally in 2022. Predictions are that these figures could rise to 29.9 million new incidences and 15.3 million deaths per year by 2040. Consequently, the rising prevalence of cancer is a driving factor in the expansion of the oral mucositis market.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=21237&type=smp
Which Oral Mucositis Market Segments Are Growing the Fastest?
The oral mucositis market covered in this report is segmented –
1) By Indication: Chemotherapy, Radiotherapy, Hematopoietic Stem Cell Transplantation
2) By Product Type: Solid Dosage Form, Liquid Dosage Form
3) By Treatment: Palifermin, Amifostine, Chlorhexidine, Sucralfate, Avasopasem, Dusquetide
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Dental Clinics, Oncology Hospitals, Research Institutes
Subsegments:
1) By Chemotherapy: High-Dose Chemotherapy-Induced Oral Mucositis, Standard-Dose Chemotherapy-Induced Oral Mucositis
2) By Radiotherapy: Head And Neck Cancer Radiotherapy-Induced Oral Mucositis, Total Body Irradiation-Induced Oral Mucositis
3) By Hematopoietic Stem Cell Transplantation: Autologous Stem Cell Transplantation-Induced Oral Mucositis, Allogeneic Stem Cell Transplantation-Induced Oral Mucositis
Which Industry Trends Are Shaping the Future of the Oral Mucositis Market?
Leading firms in the oral mucositis market are emphasizing on creating pioneering solutions like cryotherapy, a technique which employs cold therapy to diminish the impact on oral tissues, thus reducing the occurrence and intensity of the condition. This medical procedure utilizes extreme cold temperatures to destroy or freeze abnormal or diseased tissue, and it treats various conditions including warts, tumors, or injuries. For instance, Chemo Mouthpiece LLC, a medical device organization based in the US, got approval for its chemo mouthpiece device by the Food and Drug Administration, a US government agency, in February 2024. The mentioned chemo mouthpiece is an intraoral ice pack that introduces cryotherapy into a patient’s oral cavity during chemotherapy treatment. This helps in the proactive management and treatment of oral mucositis, a frequent and agonizing adverse effect of chemotherapy treatment.
Access The Full Report Here:
https://www.thebusinessresearchcompany.com/report/oral-mucositis-global-market-report
Which Countries Are Leading the Oral Mucositis Market?
North America was the largest region in the oral mucositis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the oral mucositis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21237
This Report Delivers Insight On:
1. How big is the oral mucositis market, and how is it changing globally?
2. Who are the major companies in the oral mucositis market, and how are they performing?
3. What are the key opportunities and risks in the oral mucositis market right now?
4. Which products or customer segments are growing the most in the oral mucositis market?
5. What factors are helping or slowing down the growth of the oral mucositis market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 2071930708
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model